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As the tide of chemicals born of the Industrial Age has arisen to
engulf our environment, a drastic change has come about in the
nature of the most serious public health problems.
Rachel Carson, Silent Spring, 1962
Worldwide rates of diabetes and other metabolic diseases
have exploded over the last several decades. Globally,
more than 170 million individuals currently suffer from
diabetes, and this number is projected to reach a stagger-
ing 366 million by 2030 (1). This scourge results in signif-
icant individual morbidity and mortality while contributing
to the economic fragility of healthcare systems across the
globe. In the U.S. alone, annual costs associated with di-
abetes are estimated to be $174 billion (2). As such, every
effort must be made to understand the factors underlying
this emerging metabolic disaster in order to mitigate its
deleterious impact on the individual and society. Recently,
an expanding body of scientiﬁc evidence has begun to
link exposure to synthetic chemicals with a wide variety
of diseases, including reproductive tract disorders and
neurobehavioral diseases. The present work discusses
epidemiological links between chemical exposure and dis-
orders of glucose homeostasis, experimental data demon-
strating chemical-induced changes in insulin action, and
challenges facing the ﬁeld of metabolic disruption as well
as approaches for addressing those challenges.
Originally articulated in the early 1990s, the environ-
mental endocrine disruptor theory proposes that some
exogenous chemicals interfere with endogenous hormonal
axes (3). The recognition of this potential mechanism of
action was a paradigm shift in toxicology that had pre-
viously focused on a chemical’s capacity to induce acute
toxicity or to cause cancer via mutagenesis. The Envi-
ronmental Protection Agency (EPA) deﬁnes an endocrine
disrupting chemical (EDC) as “an exogenous agent that
interferes with the production, release, transport, metabo-
lism, binding, action, or elimination of natural hormones in
the body responsible for the maintenance of homeostasis,
reproduction, development, and/or behavior” (4). Putative
EDCs include structurally diverse chemicals including or-
ganic pollutants, heavy metals, pharmaceuticals, and phy-
tochemicals, with humans exposed through agricultural
goods and consumer products, as well as water and air
contaminated with industrial waste (Fig. 1). Early studies
of EDCs focused on identifying chemicals with the ca-
pacity to modulate sex steroid and thyroid hormone sig-
naling; however, recent work suggests that some chemicals
may disturb signaling pathways critical for energy ho-
meostasis (5). Despite the potential importance of EDCs in
the pathogenesis of metabolic diseases, the contribution
of synthetic chemical exposure to the diabetes epidemic
remains largely unrecognized and underappreciated even
though U.S. diabetes rates have increased in concordance
with the national production of synthetic organic chem-
icals (Fig. 2). While such correlations are crude, emerging
data supports a biologically plausible causative link be-
tween diabetes and chemical exposure. Here, we present
data suggesting a role for some synthetic chemicals in the
pathogenesis of diabetes that merits comprehensive efforts
to address the contribution of environmental pollutants to
this burgeoning metabolic catastrophe.
Environmental obesogen hypothesis. An unequivocal
contributor to the diabetes epidemic is the metabolic stress
induced by rising rates of obesity. Increased adiposity is
closely linked to the development of insulin resistance, an
important predisposing factor in the development of type 2
diabetes. Over the last several decades, obesity rates have
exploded, with more than a third of the adult U.S. pop-
ulation now obese (6). The society-wide accumulation of
body fat is undoubtedly a consequence of a widening gap
between caloric intake and caloric expenditure resulting
from myriad social forces; however, the magnitude and
rapidity with which obesity rates have increased raise
concerns about other pathogenic factors. In 2002, Baillie-
Hamilton (7) proposed a link between the post–World
War II increase in synthetic chemical production and the
obesity epidemic. This correlation, coupled with experi-
mental evidence demonstrating that certain environ-
mental pollutants induce adipogenesis and weight gain in
experimental models, led to the environmental obesogen
hypothesis that posits a causative role for synthetic chem-
icals in the pathogenesis of obesity (rev. in 8).
While environmental obesogens have rightfully received
much discussion, it is important to recognize that obesity
per se may not lead to abnormalities in glucose homeo-
stasis. An important distinction in obesity research is the
differentiation between metabolically deleterious obesity
and the “ﬁt fat” (9). Thus, while increased fat mass may
contribute to the development of diabetes, obesity is not
a necessary or sufﬁcient condition. Insulin resistance can
arise independent of obesity, and the onset of frank di-
abetes necessitates a deﬁcit in b-cell insulin production, as
either the primary defect or the failure to compensate for
diminished insulin sensitivity. Therefore, the search for
pollution-induced diabetes should include a speciﬁc focus
on compounds with the capacity to induce insulin re-
sistance and/or impair b-cell function.
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PERSPECTIVES IN DIABETESEpidemiological evidence of diabetogenic pollutants.
Data linking diabetes to environmental pollutants have
come from a number of epidemiological studies performed
in a variety of experimental contexts (Table 1). Environ-
mental disasters such as the chemical plant explosion in
Seveso, Italy, have suggested a link between dioxin ex-
posure and diabetes (10), while rice oil contamination in
Yucheng, China, has implicated polychlorinated biphenyl
ethers (PCBs) and furans (11). Exposure of military per-
sonnel to dioxins during the Vietnam War has been asso-
ciated with a higher prevalence of diabetes and a reduced
latency to disease development (12). Several studies of
occupational exposure have suggested links between di-
abetes and organochlorine pesticides (13) or dioxins (14).
Recreational contact via consumption of sport ﬁsh from
the Great Lakes in the U.S. tied diabetes incidence with
p,p’-diphenyldichloroethene (DDE), the principle metabo-
lite of the insecticide p,p’-dichlorodiphenyltrichloroethane
(DDT) (15). A variety of international studies demonstrated
diabetogenic links to organochlorine pollutants (16) and
heavy metals (17), with some studies suggesting a speciﬁc
defect in insulin secretion but not in overall glucose toler-
ance (18). In addition to diabetes, epidemiological studies
have associated various pollutants with other measures
of disturbed glucose homeostasis, including prediabetes
(impaired fasting glucose and/or impaired glucose toler-
ance) (16), the metabolic syndrome (19), and insulin re-
sistance (20).
Many of the above studies focused on speciﬁc popula-
tions (i.e., those exposed occupationally, recreationally, or
through speciﬁc industrial accidents) that may not reﬂect
the risk posed to the general population; however, a series
of recent investigations have examined the connection
between various pollutants and measures of glucose ho-
meostasis using data from the National Health and Nu-
trition Examination Survey (NHANES), which provides
a representative sampling of the U.S. population (21).
NHANES-based studies have shown associations between
phthalates and various persistent organic pollutants (POPs)
with insulin resistance, the metabolic syndrome, and diabetes
(20,22). In addition, urinary levels of the ubiquitous plasti-
cizer, bisphenol-A (BPA), have been detected in .95% of the
NHANES cohort (23) and positively correlate with diabetes
prevalence and other metabolic derangements (24). Thus,
there is intriguing evidence suggesting possible connections
between pollutants and the development of diabetes.
There are, however, caveats that must be considered in
interpreting these studies. One signiﬁcant challenge is the
common use of cross-sectional design to correlate disease
prevalence with current EDC levels. Such analyses are
particularly problematic for chemicals that metabolize more
rapidly and exhibit fewer propensities to bioaccumulate
(e.g., BPA and phthalates) because their current levels may
differ from concentrations during disease development.
Additionally, issues related to coexposures to confounding
compounds, selection of control populations, and variability
in statistical analyses complicate data interpretation and
FIG. 1. Sources and targets of metabolic disruptors.
FIG. 2. U.S. synthetic chemical production and diabetes prevalence.
Synthetic chemical production in the U.S. from 1939 to 1994 was
obtained from the U.S. Tariff Commission reports (72). Production
from 1995 to 2008 was extrapolated using the annual index of chemical
production published by Chemical & Engineering News from 1989 to
2008 (73,74), with kilograms calculated from linear regression analysis
of overlapping data from 1989 to 1994 (r
2 = 0.948). Diabetes preva-
lence was obtained from the Centers for Disease Control and Pre-
vention (75).
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is heterogeneity in the deﬁnition of diabetes and insulin re-
sistance used in these studies. Collectively, these challenges
underscore the need for expanded longitudinal studies that
can follow chemical exposures throughout disease devel-
opment in order to better relate speciﬁc chemicals to the
pathogenesis of diabetes.
Evidence of environmental diabetogenic pollutants in
animal models. The shortcomings of epidemiological
investigations can be overcome by studying suspected di-
abetogenic chemicals using animal models. A number of
chemicals have been shown to elicit biological effects that
alter glucose homeostasis (Table 2). For instance, acute
exposure of male mice to BPA was found to reduce the
rise in plasma glucose during an intraperitoneal glucose
tolerance test; however, sustained exposure (more similar
to human exposure) resulted in hyperinsulinemia, a wors-
ening of glucose tolerance, and a concomitant reduction
in insulin sensitivity (25). Interestingly, the impairment in
insulin action occurred despite a demonstrated increase
in b-cell insulin content after both in vivo and in vitro
BPA exposure (26). One explanation for these ﬁndings
is that BPA operates through multiple mechanisms that
independently increase insulin synthesis/secretion while
simultaneously inducing peripheral insulin resistance. Alter-
natively, higher insulin levels induced by BPA may result in
a compensatory insulin resistance to limit hypoglycemia.
Regardless of the process, the overall effects of chronic BPA
exposure on glucose homeostasis suggest that it may be
a diabetogenic factor (27).
Other pollutants also disrupt glucose homeostasis in ex-
perimental models. Exposure of rats to the ﬂame retardant
polybrominated diphenyl ether signiﬁcantly increased li-
polysis while reducing insulin-stimulated glucose uptake
(28). Diethylhexyl phthalate, a common plasticizer, re-
duced insulin levels and raised serum glucose levels in
exposed rats (29), while mice treated with tributyl tin
(TBT), a fungicide and antifouling agent, demonstrated
hepatic steatosis and hyperinsulinemia (30). Recently,
rats fed ﬁsh oil naturally contaminated with a variety of
POPs demonstrated impaired glucose homeostasis, with
several chemicals in the contaminated ﬁsh oil found to
suppress insulin-stimulated glucose uptake in 3T3-L1 adi-
pocytes (31).
These results are similar to ﬁndings that 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) treatment of primary mu-
rine adipose tissue impaired insulin-stimulated glucose
uptake, likely by reducing glucose transporter 4 transcript
levels (32). In a separate model, mice exposed to TCDD
had reduced glucokinase gene expression (33), predicting
a rise in blood glucose levels analogous to that seen in
maturity-onset diabetes of the young type 2. Others have
suggested that the diabetogenic effects of TCDD are me-
diated through an antagonism of peroxisome proliferator–
activated receptor-g (PPARg) action (34) or through
upregulation of the inﬂammatory adipokine tumor necro-
sis factor-a (TNF-a) in adipocytes (35). While these data
are consistent with epidemiological observations linking
TCDD exposure to diabetes, other studies have shown that
TCDD has hypoglycemic effects. In a rat model of diabetes
incorporating high-fat diet coupled with streptozotocin
treatment, TCDD treatment reduced plasma glucose levels
(36). However, this study may reﬂect an alternative met-
abolic disruption of quasi-starvation mediated through
TCDD suppression of gluconeogenesis via inhibition of
PEPCK (37). Furthermore, the hypoglycemic effects of
T
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nitude of the known lethal dose for rat. The apparent in-
congruence between hypoglycemic and hyperglycemic
observations likely reﬂects dose-dependent effects. Such
ﬁndings underscore the need for mechanistic studies over
wide concentration ranges that reﬂect both variability in
human exposure and the potential for different mecha-
nisms to predominate at different concentrations.
Putative diabetogenic mechanisms
Traditional endocrine disruption. Historically, EDC
research has focused on the ability of exogenous chem-
icals to modulate the activity of classic nuclear hormone
receptors, including those for estrogens, androgens, and
thyroid hormone. Several of these pathways appear to be
critically important for energy regulation in general and
glucose homeostasis in particular. For example, knockout
models of aromatase and the estrogen receptor-a demon-
strate the capacity of estrogens to augment glucose toler-
ance and insulin sensitivity (38,39). However, the effects of
estrogen on insulin action may be context-dependent, as
conditions associated with estrogen levels that are both
high (e.g., pregnancy) and low (e.g., menopause) correlate
with insulin resistance. BPA is known to have estrogenic
properties, and as mentioned, prolonged treatment of male
mice with this EDC induces changes consistent with a di-
abetic phenotype (25). Furthermore, the augmentation in
b-cell insulin content after BPA exposure appears to be
a direct result of its estrogenic properties, as the effect was
not observed in estrogen receptor-a–knockout animals
(26). Because estrogens can have divergent effects on
TABLE 2
Animal studies demonstrating EDC-induced changes in glucose homeostasis
Author EDC Model system Disruption of glucose homeostasis
Weber et al., Toxicology
1991;66:133–144
TCDD Wild-type male Sprague
Dawley rats
Injection of 25 mg/kg TCDD resulted in decreased
activity of PEPCK and G-6-Pase after 2 and 8 days of
treatment, respectively.
Liu et al., Mol Pharmacol
1995;47:65–73
TCDD Wild-type male C57BL/6
and DBA/2J mice
A single dose of 116 mg/kg i.p. TCDD resulted in the
signiﬁcant decrease in glucose transport in adipose
tissue and brain after 24 h that was sustained for
at least 30 days. The effect was AhR mediated.
Gayathri et al., Indian J Med
Res 2004;119:139–144
DEHP Wild-type female Wistar
Kyoto rats
Administration of 75 mg/kg DEHP every other day for
14 days resulted in a decrease in serum insulin and
cortisol as well as liver glycogen; blood glucose was
increased. The effects were reversible upon stopping
treatment.
Alonso-Magdalena et al.,
Environ Health Perspect
2006;114:106–112
BPA Wild-type male Swiss
albino OF1 mice
Administration of a single 10 mg/kg dose of BPA produced
a rapid rise in plasma insulin and a corresponding
decrease in plasma glucose; however, 4-day treatment
with 100 mg/kg/day of BPA impaired glucose tolerance
on an intraperitoneal glucose tolerance test and
reduced the hypoglycemic effect of insulin in an insulin
tolerance test.
Hoppe and Carey, Obesity
2007;15:2942–2950
Penta-BDE Wild-type male Sprague
Dawley rats
Daily gavage of 14 mg/kg penta-BDE for 4 weeks
resulted in a 30% increase in isoproterenol-stimulated
lipolysis and a 59% decrease in insulin-stimulated
glucose oxidation in adipocytes.
Alonso-Magdalena et al.,
PLoS One 2008;3:e2069
BPA Wild-type male Swiss
albino OF1 mice and
ERa and ERb KO mice
Administration of 100 mg/kg BPA twice per day for 4 days
resulted in a signiﬁcant increase in b-cell insulin content
that was ERa dependent. Isolated islets treated with
1 nmol/L BPA had an increase in insulin content.
Sato et al., Toxicol Appl
Pharmacol 2008;229:1019
TCDD Wild-type male C57BL/6
and AhR KO mouse
Oral administration of 500 ng/kg TCDD once a day for
18 days resulted in signiﬁcantly increased CYP1A1
expression in the liver and changes in energy
metabolism gene expression that was AhR-mediated.
Ruzzin et al., Environ Health
Perspect 2010;118:465–471
General POPs Wild-type male Sprague
Dawley rats
Administration of a crude ﬁsh oil diet for 28 days resulted
in systemic insulin resistance, visceral fat accumulation,
and hepatosteatosis. Several genes regulating hepatic
lipid metabolism were altered. Isolated POP classes
impaired insulin-stimulated glucose uptake in 3T3-L1
adipocytes.
Fried et al., Drug Chem
Toxicol 2010;33:261–268
TCDD Wild-type male Sprague
Dawley rats
Diabetic rats (high-fat diet/streptozotocin treatment) dosed
with 12.8 mg/kg TCDD had signiﬁcantly reduced serum
glucose levels by day 8 of treatment.
Zuo et al., Environ Toxicol
2011;26:79–85
TBT Wild-type male KM mice Oral administration once every 3 days for 45 days of
0.5–50 mg/kg TBT resulted in body weight gain,
hepatic steatosis, hyperinsulinemia, hyperleptinemia,
and a reduction in hepatic adiponectin levels in a
dose-dependent fashion.
BDE, bromodiphenyl ether; DEHP, di(2-ethylhexyl)-phthalate; G-6-Pase, glucose-6-phosphatase.
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tion differently depending on the background hormonal
milieu. Thus, the experimental effects may differ between
males and females as well as among females at various
stages of their reproductive lives (i.e., prepubertal, post-
menopausal, or reproductive age).
Androgens also appear to modulate insulin sensitivity.
For example, emerging data suggests that low androgen
levels in men correlate with insulin resistance. In the
TIMES2 trial, testosterone treatment of hypogonadal men
with diabetes or the metabolic syndrome improved insulin
sensitivity as assessed by homeostasis model assessment
of insulin resistance (HOMA-IR) (40). In contrast, exposure
to androgens can also adversely affect glucose tolerance.
Rhesus monkeys prenatally exposed to androgens show
evidence of insulin resistance, with the females having
features consistent with the polycystic ovarian syndrome
(PCOS) phenotype (41). In humans, insulin resistance is
an important clinical feature of PCOS. Interestingly, re-
cent data suggests that women with PCOS have higher
levels of BPA than control subjects, and among these
PCOS patients, BPA levels correlated with measures of
insulin resistance (42). Various synthetic chemicals have
t h ec a p a c i t yt of u n c t i o na sb o t ha n d r o g e na g o n i s t sa n d
antagonists (43), suggesting their capacity to disrupt glu-
cose homeostasis. Importantly, these data also emphasize
the potential importance of the timing, context, and relative
balance of EDCs on the overall impact of chemical expo-
sure on diabetes risk.
Given the central role of thyroid hormone in energy
metabolism, disruption of normal thyroid hormone action
may facilitate the development of a diabetic phenotype.
Many chemicals can disrupt the thyroid hormone axis (44),
and levels of several thyroid disruptors have been corre-
lated with diabetes in epidemiological studies, including
PCBs (45). Likewise, glucocorticoids are known modu-
lators of energy metabolism, and recent data suggest that
some EDCs may have the capacity to stimulate signaling
through the glucocorticoid receptor (46) or by altering
glucocorticoid synthesis or activation (47,48). EDCs with
glucocorticoid-like activity would be predicted to diminish
insulin sensitivity and foster a diabetic phenotype.
Other ligand-activated nuclear hormone receptors are
important for energy regulation and have been implicated
as EDC targets. Of particular interest are EDCs activating
the PPARs. For example, TBT promotes adipogenesis by
stimulating PPARg and its obligate heterodimeric partner
retinoid X receptor (RXR) in mouse models (49) and human
mesenchymal stem cell cultures (50). Conversely, TCDD
inhibits adipogenesis through a suppression of PPARg (51).
The proadipogenic effects of TBT and other EDCs serve
as the basis for the environmental obesogen hypothesis.
Nevertheless, while PPARg promotes fat accumulation,
its activation also increases insulin sensitivity; this is the
rationale for using thiazolidinediones to treat diabetes.
Despite this, TBT may impair insulin sensitivity (30);
however, this may reﬂect its promiscuous activation of
heterodimeric partners of RXR other than PPARg.E D C -
mediated effects on nuclear hormone signaling are emerg-
ing as important mechanisms of metabolic disruption;
however, work remains to clarify whether these com-
pounds alter signaling directly at the ligand binding site
or whether indirect mechanisms such as coactivator/
corepressor recruitment, ligand activation, allosteric effects,
targeted receptor degradation, or others are the principle
modes of action.
Cross-talk between xenobiotic signaling and metabo-
lism. In addition to the traditional hormone receptors, the
superfamily of ligand-activated nuclear hormone recep-
tors includes several members that function primarily
in the sensing and detoxiﬁcation of foreign compounds,
i.e., xenobiotics. These include the aryl hydrocarbon re-
ceptor (AhR), the pregnane X receptor, and the constitutive
androstane receptor. In addition to their role in the in-
duction of drug metabolizing enzymes, these receptors
have modulating effects on lipid and glucose metabolism
through their interaction with a wide array of other nuclear
receptors (e.g., thyroid hormone receptor, glucocorticoid
receptor, PPARa,P P A R g) and transcription factors (e.g.,
CREB, FOXO1, PGC1a) involved in energy regulation;
moreover, the xenobiotic receptors appear to inﬂuence
inﬂammatory responses (52). Interestingly, AhR was orig-
inally identiﬁed as the receptor for dioxin, one of the
chemicals most frequently associated with diabetes in ep-
idemiological studies. It is intriguing to speculate that xe-
nobiotic receptors evolved in part to adjust metabolic
pathways to environmental stressors, and that the pro-
liferation of anthropogenic chemicals in the environment
has overwhelmed these adaptive processes, thereby con-
tributing to the onset of metabolic diseases.
Epigenetic changes. In line with the “developmental
origins of adult disease” hypothesis, a recent emphasis in
EDC research has been focused on the effects of in utero
and early postnatal chemical exposure on the genesis
of adult diseases through modulation of the epigenome.
Exposure to a variety of pollutants appears to modify the
epigenome (53), and concerning evidence demonstrates
that chemical-induced epigenetic changes can be heritable.
In a rat model, exposure of pregnant dams to the fungicide
vinclozolin led to transgenerational epigenetic modiﬁca-
tions into at least the F4 generation (54). Intriguingly, there
is now data demonstrating the epigenetic regulation of
various genes inﬂuencing metabolic diseases, including
diabetes (55). While links between EDC exposure and epi-
genetic alterations of genes controlling energy metabolism
have yet to be described, current evidence supports the
contention that exposure to EDCs may inﬂuence the
metabolic state of an individual, with the potential for these
effects to be transmitted to subsequent generations.
Alternative mechanisms. EDC effects on other molecu-
lar mechanisms implicated in the development of di-
abetes, e.g., inﬂammation and oxidative stress, have only
recently been considered. For example, PCB-77 has been
shown to promote expression of the proinﬂammatory
adipokines interleukin-6 (IL-6) and TNF-a, leading to im-
paired insulin signaling in endothelial cells (56). BPA
treatment of human adipose tissue explants also augments
secretion of IL-6 and TNF-a while simultaneously in-
hibiting the release of the insulin-sensitizing adipokine adi-
ponectin (57). Interestingly, the detoxiﬁcation of exogenous
chemicals by the cytochrome P450 enzymes generates ox-
idative stress, which may promote hepatic insulin resistance
due to the liver’s dual role in energy and drug metabolism
(58). Other diabetogenic mechanisms such as induction of
endoplasmic reticulum stress, implicated in arsenic-induced
b-cell apoptosis (59), are intriguing but remain poorly
studied. With the plethora of structurally diverse com-
pounds present in the environment, these and additional
mechanisms may be relevant in the disruption of energy
regulation. Characterizing the relevant mechanisms is crit-
ical for identifying potential pharmaceutical targets to treat
environmentally induced diabetes.
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As alluded to above, there are a number of challenges lim-
iting our understanding of the impact of synthetic chemicals
on metabolic diseases that relate to the chemicals them-
selves, the exposed individuals, and the experimental ap-
proach used to study EDC effects on glucose homeostasis
(Table 3). The tens of thousands of unique chemicals re-
leased into the environment create an enormous analytical
challenge in quantifying human exposure while the physical
properties of some compounds contribute to their bio-
accumulation and persistence in human tissues long after
the exposure has terminated. This contributes to the
near ubiquity of certain EDCs in the U.S. population (e.g.,
hexachlorobenzene and DDE) (23) and raises important
questions about the threshold of exposure necessary to elicit
a disease phenotype. The experimental challenge is further
complicated by the lack of clear structure-function rela-
tionships that preclude in silico prediction of adverse health
effects, thereby necessitating the use of bioassays to char-
acterize the physiological effects of chemical exposure.
Inter-individual variation in gene-environment inter-
actions may also modify the deleterious effects of synthetic
chemicals. For example, the adverse consequences of oc-
cupational exposure to pesticides among Costa Rican
banana farmers was found to be inﬂuenced by whether
they inherited “favorable” or “unfavorable” metabolizing
genes (60). Other predisposing factors, such as obesity or
a family history of diabetes, may also accentuate the di-
abetogenic effects of some chemicals (61), while high-fat
diets may augment exposure to lipophilic EDCs. As dis-
cussed, EDCs that modulate sex steroid action may have
divergent metabolic effects depending on the background
hormonal milieu leading to sexually dimorphic effects that
are also inﬂuenced by changes over the life span. Finally,
evidence of in utero programming and transgenerational
effects suggest that an individual’s disease-related expo-
sure may have taken place before birth or even in a prior
generation.
Lastly, experimental design may inﬂuence the observed
biological effect or fail to accurately recapitulate real-
world scenarios. Particularly vexing are mixtures of
compounds that may exert additive, antagonistic, or even
synergistic biological effects. Consequently, the ultimate
metabolic phenotype may differ considerably from studies of
single chemicals in isolation. Furthermore, nonmonotonic
dose-response relationships are seen with some chemicals
(e.g., BPA [62] and polybrominated diphenyl ethers [19]),
thus mandating studies across wide concentration ranges
that also account for effects at extremely low doses. Fi-
nally, animal models and humans may have divergent
responses to EDCs (63), and the phytochemical content of
animal feeds modulates EDCs effects (64). Thus, careful
selection of experimental models and appropriate controls
are critical for understanding the metabolic effects of
synthetic chemicals.
Diabetes and environmental injustice. One of the pro-
found tragedies of the diabetes epidemic is its dispropor-
tionate effect on minority groups and the economically
disadvantaged. National survey data from 2007–2009 show
that 11.8% of Hispanics and 12.6% of non-Hispanic blacks
self-identiﬁed as having diabetes compared with only 7.1%
of non-Hispanic whites (65). Furthermore, rates of diabetes
are inversely related to household income and education
level (66). This heightened risk may reﬂect disproportionate
exposure to chemical pollutants among these groups (67).
Some studies have speciﬁcally linked chemical exposure
with diabetes among high-risk groups, including Mexican
Americans (68) and Native Americans (69), while others
have found stronger associations between POPs and dia-
betes among Hispanics (22). This strengthened association
may reﬂect coordinate exposure to other diabetes-promoting
chemicals, increased susceptibility to metabolic disruption
(e.g., in 60), or an interaction between diabetogenic chem-
icals and other predisposing risk factors, e.g., diet or lim-
ited access to healthcare. The greater synthetic chemical
exposure of poor and minority groups is likely a conse-
quence of many factors; however, one important contrib-
utor is the historical construction of chemical production
facilities and toxic waste sites in poor communities (70).
The causality of these intertwined relationships is difﬁcult
to dissect; nevertheless, the synergy of coexisting poverty,
poor education, and pollution likely contributes to the
pathogenesis of metabolic diseases.
Strategies for change. Mitigation of the detrimental ef-
fects of pollution on metabolic health will require the de-
velopment and implementation of comprehensive strategies,
including expanded research programs, improved regula-
tion and public policy, and education efforts (Fig. 3). The
EPA has recently begun analyzing synthetic chemicals
for endocrine-disrupting effects through the Endocrine
TABLE 3
Challenges in endocrine/metabolic disruption of glucose
homeostasis
Challenges related to the chemicals
Number of structurally diverse compounds to which humans
are exposed
Measurement of chemicals in metabolically-relevant tissues
Lack of clear structure-function relationships
Multiple mechanisms of action for a single chemical
Effects mediated by a chemical’s metabolites
Chemical breakdown differing by route of exposure
Interactions among chemicals
Additive, antagonistic, and synergistic effects
Interactions between chemicals and endogenous metabolites
Persistence of chemicals
Ubiquity of exposure to some chemicals
Challenges related to exposed individuals
Interindividual genetic susceptibility to EDCs
Differences in EDC target genes
Differences in genes regulating EDC metabolism
Coexisting diabetes risk factors
Obesity, high-fat diet, sedentary lifestyle, family history
Medical comorbidities
Pharmaceutical agents/medications
Hormonal status
Women versus men
Prepubertal versus reproductive age versus postmenopausal
Eugonadal versus hypogonadal
Challenges related to experimental design and approaches
Cross-sectional versus longitudinal epidemiological design
Single chemical approaches versus analyses of mixtures
Additive, antagonistic, and synergistic effects
Nonmonotonic dose-response relationships
Failure of cell culture or animal models to recapitulate human
physiology
Background hormonal milieu of experimental animals
Effect of timing of exposure
in utero or early postnatal versus adult exposure
Transgenerational effects
Phytochemical content of animal feed
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panded to include analyses of metabolic disruption in order
to speciﬁcally identify diabetogenic chemicals with sig-
niﬁcant emphasis placed on characterizing the molecular
mechanisms in order to better identify health-threatening
chemicals, to anticipate additive/synergistic effects of mix-
tures, and to determine potential pharmaceutical targets.
Susceptibility across the life span should be assessed with
special emphasis on critical developmental windows and
transgenerational effects.
Risk analysis can be enhanced by identifying groups
with exposures to high-risk chemicals and achieving a
better understanding of factors predisposing to disruptions
in energy homeostasis, including genetic polymorphisms
linked to detoxiﬁcation and metabolic pathways. Exposure
analysis must be expanded beyond urine and serum to
include lipid-rich organs that bioaccumulate POPs (e.g.,
brain and adipose) as well as tissues relevant to in utero
and early postnatal exposure (e.g., human breast milk, cord
blood, and placental tissue). Beyond direct measurement of
EDCs, development of clinical biomarkers will facilitate
identiﬁcation of chemical-exposed individuals who can
then be monitored prospectively for the development of
diabetes, enhancing efforts to establish causality.
The new toxicology paradigm of endocrine and meta-
bolic disruption mandates a transformation in regulatory
policy to limit the production and use of chemicals that
threaten metabolic health. Speciﬁc attention should be
paid to banning chemicals with long-lasting efforts due to
either their environmental persistence or ability to induce
transgenerational effects. When doubts persist about a
chemical’s metabolic impact, the “precautionary principle”
should be adopted and its use restricted. Whenever pos-
sible, decontamination of environments and individuals
exposed to metabolic disruptors should be pursued to limit
ongoing exposure. For individuals with exposures that
cannot be cleared, drugs should be developed to modulate
the speciﬁc pathways responsible for pollution-induced
diabetes. Finally, scientists and clinicians must become
advocates in educating lawmakers and the public about
the threat of metabolic disruptors as well as the means to
limit their impact through sound government policy and
smart consumer choices.
Conclusions. In 1962, Rachel Carson warned of the health
threat posed by environmental pollution (71). Nearly 50
years later, evidence suggests that human exposure to syn-
thetic chemicals may be contributing to the burgeoning
diabetes epidemic. While the revolution in synthetic chem-
istry has facilitated vast improvements in our quality of life,
these beneﬁts increasingly appear to have come with a hidden
cost. This paradox of progress now mandates a reassessment
of how our consumption habits negatively impact our
metabolic health in order to devise effective strategies to
limit the signiﬁcant individual and societal toll of diabetes.
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